Sabra Health Care REIT, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 569.54M | 624.81M | 647.51M | 703.24M | 774.63M | 10.2% | |
| Cost of Revenue | (141.20M) | (162.61M) | (195.25M) | (227.09M) | (271.11M) | 19.4% | |
Gross Profit | 428.34M | 462.20M | 452.27M | 476.15M | 503.53M | 5.8% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (34.67M) | (39.57M) | (47.47M) | (50.07M) | (53.71M) | 7.3% | |
| General & Administrative | (34.67M) | (39.57M) | (47.47M) | (50.07M) | (53.71M) | 7.3% | |
| Depreciation & Amortization | (178.99M) | (187.78M) | (183.09M) | (169.62M) | (187.00M) | 10.2% | |
Operating Income (EBIT) | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M | 2.7% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (98.63M) | (105.47M) | (112.96M) | (115.27M) | (112.49M) | -2.4% | |
| Other Income/Expenses (Net) | -322.16M | -311.20M | -205.95M | -129.31M | -106.52M | -17.6% | |
Income Before Tax | -111.41M | -76.36M | 15.76M | 127.72M | 157.35M | 23.2% | |
| Income Tax Expense | (1.84M) | (1.24M) | (2.00M) | (1.00M) | (1.84M) | 82.8% | |
Net Income | -113.26M | -77.61M | 13.76M | 126.71M | 155.61M | 22.8% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-1 | $-0 | $0 | $1 | $1 | 18.5% | |
| Weighted Avg Shares Outstanding | 219.07M | 230.95M | 231.20M | 233.50M | 241.31M | 3.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.50M | 3.6% | |
EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M | 10.7% |
Explore SBRA
SBRA in the Real Estate
Mid Cap